Filter Results
:
(44)
Show Results For
-
All HBS Web
(2,397)
- Faculty Publications (44)
Show Results For
-
All HBS Web
(2,397)
- Faculty Publications (44)
Page 1 of
44
Results
→
Are you looking for?
MS/MBA Biotechnology: Life Sciences Webinar Discover the new MS/MBA Biotechnology: Life Sciences Program, the two-year joint degree that blends...
As a senior at Hamilton College, I debated what career path to take. Should I go to Medical School? Maybe get a PhD? Or should I dive straight into...
- February 2021
- Case
Marie Curie: Changing the World
By: Robert L. Simons and Shirley Sun
This case describes the rise of Marie Curie from a poor family in Poland to the pinnacle of scientific fame. The case describes how Curie, as a young woman interested in science, found a way to earn a doctorate at the Sorbonne and perform pathbreaking research on...
View Details
- 2020
- Book
Healthy Buildings: How Indoor Spaces Drive Performance and Productivity
By: Joseph Allen and John D. Macomber
By the time you reach 80, you will have spent 72 years of your life indoors. Like it or not, humans have become an indoor species. This means that the people who design, build, and maintain our buildings can have a major impact on our health.
Ever feel tired... View Details
Ever feel tired... View Details
Keywords:
Architecture;
Real Estate Development;
Air Pollution;
Air Quality;
Public Health;
Productivity Gains;
Buildings And Facilities;
Health;
Pollutants;
Performance Productivity;
Construction Industry
Allen, Joseph, and John D. Macomber. Healthy Buildings: How Indoor Spaces Drive Performance and Productivity. Cambridge, MA: Harvard University Press, 2020.
- November 2019 (Revised April 2020)
- Technical Note
The Life Sciences Revolution: A Technical Primer
By: Gary P. Pisano, William J. Anderson, Amitabh Chandra, Clarissa Ceruti and Stephanie Oestreich
For more than two decades, scientific advances have been driving profound changes in drug discovery and the drug industry itself. This case provides an overview and description of these technical and scientific advances. Written for the nonscientific reader, it may be...
View Details
Keywords:
science;
Technological Innovation;
Technology;
Pharmaceutical Industry;
Biotechnology Industry
Pisano, Gary P., William J. Anderson, Amitabh Chandra, Clarissa Ceruti, and Stephanie Oestreich. "The Life Sciences Revolution: A Technical Primer." Harvard Business School Technical Note 620-054, November 2019. (Revised April 2020.)
- Article
Valuing Time Over Money Predicts Happiness After a Major Life Transition: A Preregistered Longitudinal Study of Graduating Students
By: A.V. Whillans, Lucia Macchia and Elizabeth Dunn
When making major life decisions—such as choosing what to do after graduation—is it better to prioritize time or money? In a pre-registered longitudinal study of 1,232 graduating university students, respondents who valued time over money chose more intrinsically...
View Details
Keywords:
Time Use;
Money;
Trade-offs;
Career Decisions;
Time Management;
Money;
Happiness;
Values And Beliefs;
Personal Development And Career
Whillans, A.V., Lucia Macchia, and Elizabeth Dunn. "Valuing Time Over Money Predicts Happiness After a Major Life Transition: A Preregistered Longitudinal Study of Graduating Students." Science Advances 5, no. 9 (September 2019).
- December 2018
- Case
Corporate Transformation at Merck KGaA, Darmstadt, Germany
By: Joseph B. Fuller, Amy C. Edmondson, Daniela Beyersdorfer and Tonia Labruyere
When Stefan Oschmann became CEO and chairman of the executive board of Merck KGaA, Darmstadt, Germany, in 2016, the company had started its transformation from a mid-tier traditional German industry player to a global modern science and technology player. The...
View Details
Keywords:
Corporate Governance With Family Ownership;
Transformation;
Change Management;
Restructuring;
Corporate Governance;
Family Ownership
Fuller, Joseph B., Amy C. Edmondson, Daniela Beyersdorfer, and Tonia Labruyere. "Corporate Transformation at Merck KGaA, Darmstadt, Germany." Harvard Business School Case 319-072, December 2018.
- 2018
- Chapter
Pharmaceutical Trends, Not What They Seem
By: Kyle Myers and Mark Pauly
Myers, Kyle, and Mark Pauly. "Pharmaceutical Trends, Not What They Seem." In Managing Discovery in the Life Sciences: Harnessing Creativity to Drive Biomedical Innovation, by Philip A. Rea, Mark V. Pauly, and Lawton R. Burns, 18–42. Cambridge: Cambridge University Press, 2018.
- April 2018
- Article
Extreme Teaming in an Uncertain World
By: Amy C. Edmondson
Edmondson, Amy C. "Extreme Teaming in an Uncertain World." Life Science Leader (April 2018).
- January 2017 (Revised March 2017)
- Case
Royal DSM: From Continuous Transformation to Organic Growth
By: William W. George, Carin-Isabel Knoop and Amram Migdal
Royal DSM CEO Feike Sijbesma was pondering the challenges of shifting DSM’s global organization from the constant transformations of the past 100 years to creating organic growth. When Sijbesma took the helm as CEO in 2007, he further pushed and completed the company’s...
View Details
Keywords:
Organic Growth;
Organizational Change;
M&a;
Mergers And Acquisitions;
Divestment;
Business Ventures;
Business Divisions;
Business Growth And Maturation;
Restructuring;
Change;
Change Management;
Transformation;
Transition;
Engineering;
Chemicals;
Mining;
Ethics;
Values And Beliefs;
Finance;
Capital Markets;
Financial Markets;
Food;
Globalization;
Global Strategy;
Globalized Firms And Management;
Globalized Markets And Industries;
Health;
Nutrition;
History;
Leadership;
Leadership Development;
Leadership Style;
Leading Change;
Management;
Business Or Company Management;
Growth And Development Strategy;
Growth Management;
Management Practices And Processes;
Management Style;
Organizations;
Corporate Social Responsibility And Impact;
Mission And Purpose;
Organizational Change And Adaptation;
Organizational Culture;
Organizational Design;
Ownership;
Public Ownership;
Performance;
Strategy;
Adaptation;
Consolidation;
Corporate Strategy;
Value;
Value Creation;
Biotechnology Industry;
Chemical Industry;
Food And Beverage Industry;
Mining Industry;
Pharmaceutical Industry;
Europe;
Netherlands
George, William W., Carin-Isabel Knoop, and Amram Migdal. "Royal DSM: From Continuous Transformation to Organic Growth." Harvard Business School Case 317-063, January 2017. (Revised March 2017.)
- January 2017
- Case
Danaher Corporation, 2007–2017
By: John R. Wells and Gabriel Ellsworth
On July 2, 2016, Danaher Corporation completed the spinoff of Fortive Corporation. The previous day, Danaher’s stock price had reached an all-time high. In 2015, Danaher had decided to split off its test and measurement, fuel and fleet management, and automation...
View Details
Keywords:
Danaher;
Fortive;
Larry Culp;
Beckman Coulter;
Pall;
Life Sciences;
Diagnostics;
Environmental Operations;
Water Management;
Dental;
Testing;
Measurement;
Fuel;
Fleet Management;
Automation;
Toolmaking;
Tools;
Disease Management;
Continuous Improvement;
Toyota Production System;
Divestiture;
Spinoffs;
Spin-off;
Networks;
Acquisition;
Mergers And Acquisitions;
Business Conglomerates;
Business Divisions;
Business Subsidiaries;
Business Units;
Business Growth And Maturation;
Business Model;
For-profit Firms;
Joint Ventures;
Restructuring;
Engineering;
Chemicals;
Construction;
Machinery And Machining;
Profit;
Revenue;
Globalized Firms And Management;
Multinational Firms And Management;
Health;
Health Care And Treatment;
Health Disorders;
Medical Specialties;
Business History;
Job Cuts And Outsourcing;
Business Or Company Management;
Growth And Development Strategy;
Management Analysis, Tools, And Techniques;
Management Practices And Processes;
Management Succession;
Management Systems;
Resource Allocation;
Market Entry And Exit;
Measurement And Metrics;
Logistics;
Business Processes;
Organizational Change And Adaptation;
Public Ownership;
Problems And Challenges;
science;
Genetics;
Natural Environment;
Wastes And Waste Processing;
science-based Business;
Opportunities;
Strategy;
Adaptation;
Business Strategy;
Competition;
Competitive Strategy;
Competitive Advantage;
Consolidation;
Corporate Strategy;
Diversification;
Expansion;
Technology;
Software;
Technology Networks;
Technology Platform;
Value;
Valuation;
Aerospace Industry;
Auto Industry;
Biotechnology Industry;
Chemical Industry;
Computer Industry;
Construction Industry;
Consumer Products Industry;
Distribution Industry;
Electronics Industry;
Food And Beverage Industry;
Health Industry;
Industrial Products Industry;
Information Technology Industry;
Manufacturing Industry;
Medical Devices And Supplies Industry;
Pharmaceutical Industry;
Retail Industry;
Rubber Industry;
Semiconductor Industry;
Shipping Industry;
Technology Industry;
Telecommunications Industry;
Utilities Industry;
United States;
District Of Columbia
Wells, John R., and Gabriel Ellsworth. "Danaher Corporation, 2007–2017." Harvard Business School Case 717-464, January 2017.
- November 2016
- Case
QuintilesIMS: Biosimilar Marketing in England
By: John A. Quelch and Emily C. Boudreau
QuintilesIMS was a leading healthcare consulting firm best known for its data and information offerings as well as its market research and management consulting services for life science companies. By 2015, the company was expanding beyond the biopharmaceutical...
View Details
Keywords:
Health;
Pharmaceutical Industry;
Biotech;
Marketing;
Health Care And Treatment;
Biotechnology Industry;
England
Quelch, John A., and Emily C. Boudreau. "QuintilesIMS: Biosimilar Marketing in England." Harvard Business School Case 517-054, November 2016.
- 2016
- Book
Antonio Serra and the Economics of Good Government
By: Rosario Patalano and Sophus A. Reinert
Little is known of Antonio Serra except that he wrote his extraordinary 1613 Short Treatise on the Causes That Make Kingdoms Abound in Gold and Silver even in the Absence of Mines in a Neapolitan jail and that he died there soon afterwards. However, the...
View Details
Patalano, Rosario and Sophus A. Reinert, eds. Antonio Serra and the Economics of Good Government. Palgrave Studies in the History of Finance. New York: Palgrave Macmillan, 2016.
- Article
Valuing Time Over Money Is Associated with Greater Happiness
By: Ashley V. Whillans, Aaron C. Weidman and Elizabeth W. Dunn
How do the trade-offs that we make about two of our most valuable resources—time and money—shape happiness? While past research has documented the immediate consequences of thinking about time and money, research has not yet examined whether people’s general...
View Details
Keywords:
Well-being;
Happiness;
Time;
Money;
Trade-offs;
Orientations;
Happiness;
Money;
Satisfaction
Whillans, Ashley V., Aaron C. Weidman, and Elizabeth W. Dunn. "Valuing Time Over Money Is Associated with Greater Happiness." Social Psychological & Personality Science 7, no. 3 (April 2016): 213–222. (Most read publication in SPPS in December & January, 2016. This publication was featured in the "Top 10 Insights from the Science of a Meaningful Life in 2016" by the Greater Good Science Center at UC Berkeley.)
- July 2014 (Revised January 2017)
- Course Overview Note
Building Life Science Businesses Spring Term 2017: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Spring 2016 class Building Life Science Businesses.7
View Details
Keywords:
Healthcare Ventures;
Entrepreneurial Management;
Entrepreneurship;
Entrepreneurs;
Health Care And Treatment;
Health Testing And Trials;
Medical Specialties;
Health Industry;
Biotechnology Industry;
Medical Devices And Supplies Industry;
Asia;
North America;
Europe
Hamermesh, Richard G. "Building Life Science Businesses Spring Term 2017: Course Outline and Syllabus." Harvard Business School Course Overview Note 815-003, July 2014. (Revised January 2017.)
- May 2014 (Revised November 2014)
- Case
Houston We Have A Problem: NASA and Open Innovation (A)
By: Michael Tushman, Hila Lifshitz-Assaf and Kerry Herman
Jeff Davis, director of Space Life Sciences Directorate (SLSD) at NASA, has been working for several years to raise awareness amongst scientists and researchers in his organizations of the benefits of open innovation as a successful and efficient way to collaborate on...
View Details
Tushman, Michael, Hila Lifshitz-Assaf, and Kerry Herman. "Houston We Have A Problem: NASA and Open Innovation (A)." Harvard Business School Case 414-044, May 2014. (Revised November 2014.)
- May 2014 (Revised November 2014)
- Supplement
Houston We Have A Solution: NASA and Open Innovation (B)
By: Michael Tushman, Hila Lifshitz-Assaf and Kerry Herman
Jeff Davis, director of Space Life Sciences Directorate at NASA, has been working for several years to raise awareness amongst scientists and researchers in his organizations of the benefits of open innovation as a successful and efficient way to collaborate on...
View Details
Tushman, Michael, Hila Lifshitz-Assaf, and Kerry Herman. "Houston We Have A Solution: NASA and Open Innovation (B)." Harvard Business School Supplement 414-057, May 2014. (Revised November 2014.)
- 2014
- Working Paper
The Organizational and Geographic Drivers of Absorptive Capacity: An Empirical Analysis of Pharmaceutical R&D Laboratories
By: Francesca Lazzeri and Gary P. Pisano
Scholars and practitioners alike now recognize that a firm's capacity to assimilate and use know-how from external sources—what Cohen and Levinthal (1990) called "absorptive capacity"—plays a central role in innovation performance. In recent years, a common strategy...
View Details
Keywords:
Geographic Location;
Industry Clusters;
Knowledge Acquisition;
Pharmaceutical Industry;
San Francisco;
San Diego;
Massachusetts
Lazzeri, Francesca, and Gary P. Pisano. "The Organizational and Geographic Drivers of Absorptive Capacity: An Empirical Analysis of Pharmaceutical R&D Laboratories." Harvard Business School Working Paper, No. 14-098, April 2014.
- February 2014
- Case
BGI: Data-driven Research
By: Willy Shih and Sen Chai
BGI has the largest installed gene-sequencing capacity in the world, and to Zhang Gengyun, general manager of the Life Sciences Division, this represented an opportunity to apply his training as a plant breeder and his early career work as a biochemist to improving...
View Details
Keywords:
Genomics;
Gene Sequencing;
Life Sciences;
Plant Breeding;
Genetics;
Human Genome Program;
Beijing Genomics Institute;
Bgi;
Rice Genome;
Technological Innovation;
Innovation Strategy;
Research;
Research And Development;
science;
Genetics;
science-based Business;
Strategy;
Commercialization;
Corporate Strategy;
Technology;
Information Technology;
Software;
Agriculture And Agribusiness Industry;
Biotechnology Industry;
Food And Beverage Industry;
China;
United States
Shih, Willy, and Sen Chai. "BGI: Data-driven Research." Harvard Business School Case 614-056, February 2014.
- August 2013
- Course Overview Note
Building Life Science Businesses Fall 2013: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Fall 2013 class Building Life Science Businesses.
View Details
Keywords:
Healthcare Ventures;
Entrepreneurial Management;
Entrepreneurship;
Entrepreneurs;
Health Care And Treatment;
Health Testing And Trials;
Medical Specialties;
Health Industry;
Biotechnology Industry;
Medical Devices And Supplies Industry;
Asia;
North America;
Europe
Hamermesh, Richard G. "Building Life Science Businesses Fall 2013: Course Outline and Syllabus." Harvard Business School Course Overview Note 814-019, August 2013.
- January 2013 (Revised September 2013)
- Case
Royal DSM: Fighting Hidden Hunger
By: Rebecca Henderson, Noah Fisher and Mary Shelman
In 2007 Royal DSM, a leading life science and materials company, entered a partnership with the World Food Programme (WFP) to combat hidden hunger around the world by providing micronutrient solutions. The case investigates the unexpectedly large impact the partnership...
View Details
Keywords:
Conflict Of Interests;
Human Needs;
Partners And Partnerships;
Global Range;
Nutrition;
science-based Business;
Non-governmental Organizations;
Service Industry;
Health Industry
Henderson, Rebecca, Noah Fisher, and Mary Shelman. "Royal DSM: Fighting Hidden Hunger." Harvard Business School Case 313-085, January 2013. (Revised September 2013.)
- September 2012 (Revised September 2012)
- Course Overview Note
Building Life Science Businesses Fall 2012: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Fall 2012 class Building Life Science Businesses
View Details
Are you looking for?
MS/MBA Biotechnology: Life Sciences Webinar Discover the new MS/MBA Biotechnology: Life Sciences Program, the two-year joint degree that blends...
As a senior at Hamilton College, I debated what career path to take. Should I go to Medical School? Maybe get a PhD? Or should I dive straight into...